NCT06760559

Brief Summary

Intra-articular hip injections are commonly used for diagnostic and therapeutic purposes but are often associated with patient anxiety and fear. The disparity between anticipated and experienced pain during these injections, as well as the role of pre-injection local anesthesia in pain modulation, remains unclear. This study investigates the difference between anticipated and experienced pain during intra-articular hip injections. In addition, the study examines the impact of pre-injection local anesthesia in 60 prospectively recruited patients, some of whom received pre-injection local anesthesia while others did not. These study findings provide valuable insights into experienced pain during intra-articular hip injections, which can be applied to improve patient experiences and treatment compliance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 2, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 2, 2022

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

December 31, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 7, 2025

Completed
Last Updated

January 22, 2025

Status Verified

January 1, 2025

Enrollment Period

12 months

First QC Date

December 31, 2024

Last Update Submit

January 19, 2025

Conditions

Keywords

paininjectionintra-articularexpectationcompliance

Outcome Measures

Primary Outcomes (1)

  • Numeric rating scales (NRS) scores

    Numeric rating scales (NRS) scores were measured before and after an injection in both, study and control groups to determine the anticipated pain compared to experienced pain after Intra-articular hip injection with or without local anasthesia.

    Questionnaire was given before the injection for anticipated pain evaluation and additional influencing factors on pain perception prior to injection and right after the injection for actual experienced pain.

Secondary Outcomes (1)

  • Beck Anxiety Inventory (BAI) and fear of injections

    Questionnaire was given before the injection for anticipated pain evaluation,Beck Anxiety Inventory (BAI) and additional influencing factors on pain perception prior to injection.

Study Arms (2)

Pre-injection superficial local anesthesia prior to Intra-articular corticosteroid injection

Procedure: Intra-articular corticosteroid injection

Patients without pre-injection local anesthesia prior to Intra-articular corticosteroid injection

Procedure: Intra-articular corticosteroid injection

Interventions

Intra-articular hip injections with and without local anastesia and questionnaire about pain and anxiety related to the procedure was administered before and after the injection to the study and control groups.

Also known as: Local anasthesia
Patients without pre-injection local anesthesia prior to Intra-articular corticosteroid injectionPre-injection superficial local anesthesia prior to Intra-articular corticosteroid injection

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing first-time intra-articular hip injection as indicated by an orthopedic surgeon either for diagnostic (e.g. lidocaine test, arthrography) and/or therapeutic (steroid injection for osteoarthritis) purposes.

You may qualify if:

  • Patients undergoing a first-time intra-articular hip injection as indicated by an orthopedic surgeon.
  • Indications for injection include:
  • Diagnostic purposes (e.g., lidocaine test, arthrography)
  • Therapeutic purposes (e.g., steroid injection for osteoarthritis)
  • Participants must be 18 years of age or older.
  • No previous hip joint injections.
  • Ability to fill in the survey questionnaire.

You may not qualify if:

  • Patients under 18 years of age.
  • Patients with a known history of hypersensitivity or allergy to the injectant material (e.g., local anesthetics, steroids).
  • Patients lacking the ability to sign informed consent or complete a survey questionnaire.
  • Patients with previous hip joint injections, due to the potential for recalling prior pain experienced.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tel Aviv Medical Center

Tel Aviv, Israel

Location

MeSH Terms

Conditions

PainPatient Compliance

Interventions

Adrenal Cortex Hormones

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

HormonesHormones, Hormone Substitutes, and Hormone Antagonists

Study Officials

  • Ehud Rath, Professor

    Tel Aviv Medical Center

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
2 Days
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 31, 2024

First Posted

January 7, 2025

Study Start

January 3, 2021

Primary Completion

January 2, 2022

Study Completion

January 2, 2022

Last Updated

January 22, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Due to medical confidentiality

Locations